Dovramilast and its Impurities

Dovramilast, also known by its research code CC-11050, is an investigational oral drug classified as a selective phosphodiesterase-4 (PDE4) inhibitor. It is being developed for its anti-inflammatory properties, particularly in conditions involving immune dysregulation and chronic inflammation. Reference standards of Dovramilast API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.